Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold?

被引：1
作者：
Johnson, Gillian G. [1 ,2 ]
Carr, Daniel F. [3 ]
Pirmohamed, Munir [3 ]
Pettitt, Andrew R. [2 ]
机构：
[1] Royal Liverpool & Broadgreen Univ Hosp Trust, Dept Haematol, Liverpool, Merseyside, England
[2] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England
[3] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England
来源：
PHARMACOGENOMICS | 2014年 / 15卷 / 07期
基金：
英国医学研究理事会;
关键词：
adverse drug reactions; bendamustine; chronic lymphocytic leukemia; cyclophosphamide; fludarabine; personalized medicine; pharmacogenomics; GENETIC-POLYMORPHISM; UNTREATED PATIENTS; HUMAN LIVER; RITUXIMAB; CYCLOPHOSPHAMIDE; BENDAMUSTINE; CHLORAMBUCIL; FLUDARABINE; EXPRESSION; VARIANTS;
D O I：
10.2217/pgs.14.60
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：897 / 900
页数：4
相关论文
共 50 条
  • [31] Venetoclax for the treatment of patients with chronic lymphocytic leukemia
    Crombie, Jennifer
    Davids, Matthew S.
    FUTURE ONCOLOGY, 2017, 13 (14) : 1223 - 1232
  • [32] Lenalidomide and Chronic Lymphocytic Leukemia
    Pilar Gonzalez-Rodriguez, Ana
    Payer, Angel R.
    Acebes-Huerta, Andrea
    Huergo-Zapico, Leticia
    Villa-Alvarez, Monica
    Gonzalez-Garcia, Esther
    Gonzalez, Segundo
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [33] Obinutuzumab in chronic lymphocytic leukemia
    Dupuis, Jehan
    FUTURE ONCOLOGY, 2015, 11 (18) : 2503 - 2513
  • [34] Chronic Lymphocytic Leukemia: Individualizing Treatment Approach
    Zelenetz, Andrew D.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 713 - 715
  • [35] Current treatment strategies for chronic lymphocytic leukemia
    Langerbeins, Petra
    Eichhorst, Barbara
    Hallek, Michael
    ONKOLOGE, 2019, 25 (11): : 1004 - 1008
  • [36] Treatment of Older Patients with Chronic Lymphocytic Leukemia
    Nicole Lamanna
    Current Hematologic Malignancy Reports, 2012, 7 : 21 - 25
  • [37] Novel Agents in the Treatment of Chronic Lymphocytic Leukemia: A Review About the Future
    Desai, Anjali Varma
    El-Bakkar, Hassan
    Abdul-Hay, Maher
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (06) : 314 - 322
  • [38] Improving treatment for patients with chronic lymphocytic leukemia
    Shanafelt, Tait D.
    HEMATOLOGY, 2012, 17 : S133 - S136
  • [39] What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Voorhies, Benjamin N.
    Stephens, Deborah M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (02)
  • [40] Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma
    Ujjani, Chaitra
    Ramzi, Pari
    Gehan, Edmund
    Wang, Hongkun
    Wang, Yiru
    Cheson, Bruce D.
    LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 915 - 920
12345